Astal Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Astal Laboratories Ltd. on BSE

Load latest

Astal Laboratories Ltd.

02 Dec 2024

85.75

6.93%

SAST

Astal Laboratories Ltd - 512600 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vupparapalli Chandra Sekhar Reddy & Others

pdf

Astal Laboratories Ltd.

02 Dec 2024

85.75

6.93%

SAST

Astal Laboratories Ltd - 512600 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Doradla Radha Krishna HUF & Others

pdf

Astal Laboratories Ltd.

29 Nov 2024

85.75

6.93%

SAST

Astal Laboratories Ltd - 512600 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Doradla Radha Krishna HUF & Others

pdf

Astal Laboratories Ltd.

29 Nov 2024

85.75

6.93%

SAST

Astal Laboratories Ltd - 512600 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vupparapalli Chandra Sekhar Reddy & Vupparapalli Pavani

pdf

Astal Laboratories Ltd.

27 Nov 2024

85.75

6.93%

Company Update

Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

Submission of intimation of allotment of Convertible Warrants.

pdf

Astal Laboratories Ltd.

27 Nov 2024

85.75

6.93%

Board Meeting

Astal Laboratories Ltd - 512600 - Board Meeting Outcome for Outcome Of The Meeting Of The …

BSE India

Intimation of the Outcome of the Meeting of the Board held on 27th November, 2024 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) (LODR) Regulations, 2015.

pdf

Astal Laboratories Ltd.

22 Nov 2024

85.75

6.93%

Board Meeting

Astal Laboratories Ltd - 512600 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/11/2024 ,inter alia, to consider and approve Allotment of 40,79,930 Convertible Warrants convertible into equity shares of face value of Rs. 10/- each at premium of Rs. 30/- each to Strategic Investors (Non-Promoters) on Preferential basis. To discuss any other matter with the permission of the chairperson.

pdf